# External Ventricular Drainage Post-Market Clinical Follow-up Registry

> **NCT05652296** · — · COMPLETED · sponsor: **Integra LifeSciences Corporation** · enrollment: 120 (actual)

## Conditions studied

- Cerebrospinal; Disorder

## Interventions

- **DEVICE:** External Ventricular Drainage (EVD)

## Key facts

- **NCT ID:** NCT05652296
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-03
- **Primary completion:** 2024-12-16
- **Final completion:** 2024-12-16
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05652296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05652296, "External Ventricular Drainage Post-Market Clinical Follow-up Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05652296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*